| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multidisciplinary review of several aspects of Asbestos-Related Lung Cancer (ARLC)
|
van Zandwijk, Nico
|
|
|
189 |
C |
p.
|
artikel
|
| 2 |
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
|
Paz-Ares, Luis
|
|
|
189 |
C |
p.
|
artikel
|
| 3 |
Clinical application of the Lung Cancer Compact PanelTM using various types of cytological specimens in patients with lung cancer
|
Kunimasa, Kei
|
|
|
189 |
C |
p.
|
artikel
|
| 4 |
Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients
|
Kloker, Linus D.
|
|
|
189 |
C |
p.
|
artikel
|
| 5 |
Contents
|
|
|
|
189 |
C |
p.
|
artikel
|
| 6 |
Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and immune checkpoint inhibition: The relevance of fractionation
|
Kraus, Kim Melanie
|
|
|
189 |
C |
p.
|
artikel
|
| 7 |
Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma
|
Kaira, Kyoichi
|
|
|
189 |
C |
p.
|
artikel
|
| 8 |
HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer
|
Saigí, Maria
|
|
|
189 |
C |
p.
|
artikel
|
| 9 |
Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma
|
Huang, Shenghao
|
|
|
189 |
C |
p.
|
artikel
|
| 10 |
Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer
|
Wang, Yun
|
|
|
189 |
C |
p.
|
artikel
|
| 11 |
Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition
|
Saal, Jonas
|
|
|
189 |
C |
p.
|
artikel
|
| 12 |
International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study
|
Molina, Thierry J.
|
|
|
189 |
C |
p.
|
artikel
|
| 13 |
Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy
|
Wang, Shasha
|
|
|
189 |
C |
p.
|
artikel
|
| 14 |
Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab
|
Stares, Mark
|
|
|
189 |
C |
p.
|
artikel
|
| 15 |
Pulmonary blastoma is successfully treated with immunotherapy and targeted therapy
|
Chen, Yicong
|
|
|
189 |
C |
p.
|
artikel
|
| 16 |
Resolving asbestos and ultrafine particulate definitions with carcinogenicity
|
Fitzgerald, Sean M.
|
|
|
189 |
C |
p.
|
artikel
|
| 17 |
Response to letter: Microwave ablation for Early-Stage Non-Small cell Lung Cancer: Don’t Put the Cart before the stereotactic Horse
|
Laeseke, Paul
|
|
|
189 |
C |
p.
|
artikel
|
| 18 |
Strengths and challenges in current lung cancer care: Timeliness and diagnostic procedures in six Dutch hospitals
|
Genet, Sylvia A.A.M.
|
|
|
189 |
C |
p.
|
artikel
|
| 19 |
Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy
|
Zhou, Ping
|
|
|
189 |
C |
p.
|
artikel
|
Tijdschrift beschrijving